New cancer drug begins human testing for Tough-to-Treat tumors
NCT ID NCT06840886
Summary
This is the first study in people testing a new drug called PHST001 for adults with advanced solid tumors that have returned or stopped responding to all available standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also look for early signs that the drug might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Duke Cancer Institute
RECRUITINGDurham, North Carolina, 27710, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
South Texas Accelerated Research Therapeutics (START)
RECRUITINGSan Antonio, Texas, 78229, United States
-
Stanford University School of Medicine
RECRUITINGPalo Alto, California, 94304, United States
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
-
University of Michigan Rogel Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
Vanderbilt-Ingram Cancer Center
NOT_YET_RECRUITINGNashville, Tennessee, 37203, United States
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.